Receptor - Based Drug Design

Author:   Paul Leff
Publisher:   Taylor & Francis Inc
Volume:   89
ISBN:  

9780824701628


Pages:   400
Publication Date:   10 April 1998
Format:   Hardback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $368.00 Quantity:  
Add to Cart

Share |

Receptor - Based Drug Design


Overview

Full Product Details

Author:   Paul Leff
Publisher:   Taylor & Francis Inc
Imprint:   CRC Press Inc
Volume:   89
Dimensions:   Width: 15.20cm , Height: 2.60cm , Length: 22.90cm
Weight:   0.910kg
ISBN:  

9780824701628


ISBN 10:   0824701623
Pages:   400
Publication Date:   10 April 1998
Audience:   College/higher education ,  Professional and scholarly ,  Postgraduate, Research & Scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Introduction, James Black Principles and Measurement of Drug-Receptor Interactions The Characterization and Classification of Receptors, Patrick P. A. Humphrey Functional Methods for Quantifying Agonists and Antagonists, Iain G. Dougall Quantification of Receptor Interactions Using Binding Methods, Sebastian Lazareno Drug Analysis Based on Signaling Responses to G-Protein-Coupled Receptors, T. Kendall Harden, José L. Boyer, and Robert W. Dougherty The Use of Electrophysiology to Improve Understanding of Drug-Receptor Interactions, John G. Connolly and Charles Kennedy Receptor-Based Drugs in Medicine Selective Adrenergic and Glucocorticoid Treatments for Asthma, David Jack Serotonin 5-HT1B/D Receptor Agonists, Graeme R. Martin Histamine H2-Receptor Antagonists, Michael E. Parsons Angiotensin Antagonists, Mark J. Robertson Experimental and Emerging Drugs -Adrenoceptor Agonists and Antagonists, J. Paul Hieble and Robert R. Ruffolo, Jr. P2U-Purinoceptor Agonists: Emerging Therapy for Pulmonary Diseases, Eduardo R. Lazarowski, William C. Watt, T. Kendall Harden, and Richard C. Boucher Muscarinic Receptor Antagonists Pharmacological and Therapeutic Utility, Richard M. Eglen NMDA Receptor Antagonists, John A. Kemp and James N. C. Kew New Trends in Drug Design Computational Chemistry in Receptor-Based Drug Design, Ad P. IJzerman, Eleonora M. van der Wenden, and Wilma Kuipers Recombinant G-Protein-Coupled Receptors as Screening Tools for Drug Discovery, A. Donny Strosberg and Prabhavathi B. Fernandes Inverse Agonists and G-Protein-Coupled Receptors, Richard A. Bond and Michel Bouvier

Reviews

valuableprovide[s ] information about established drugs as well as a number of drugs set to enter the marketplace or that are undergoing the approval process. The work is certainly current and definitive, and it contains chapters written by a number of well-known authorities in industry and acdemics. -Pharmaceutical Technology, 1999 this volume is essential reading for the users of the libraries of pharmaceutical companies and university departments of pharmacology, pharmacy, and medicinal chemistry. -Journal of Medicinal Chemistry


Author Information

Leff Paul

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List